Structural basis of the differential binding of engineered knottins to integrins αVβ3 and α5β1

Targeting both integrins αVβ3 and α5β1 simultaneously appears to be more effective in cancer therapy than targeting each one alone. The structural requirements for bispecific binding of ligand to integrins has not been fully elucidated. RGD-containing knottin 2.5F binds selectively to αVβ3 and α5β1,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Structure
Autors principals: Van Agthoven, Johannes F., Shams, Hengameh, Cochran, Frank V., Alonso, José L., Kintzing, James R., Garakani, Kiavash, Adair, Brian D., Xiong, Jian-Ping, Mofrad, Mohammad R. K., Cochran, Jennifer R., Arnaout, M. Amin
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6726563/
https://ncbi.nlm.nih.gov/pubmed/31353240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.str.2019.06.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars